Results 131 to 140 of about 4,088,174 (172)

Robust enhanced leaf model implementation for beam‐matched linear accelerators: Impact of physical leaf gap variations

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 11, November 2026.
Abstract Background Leaf‐gap variability may influence MLC modeling when implementing the Enhanced Leaf Model (ELM) in Eclipse v18.0 for beam‐matched linear accelerators (linacs) previously commissioned using legacy dosimetric leaf gap (DLG)–based models.
Soyoung Lee   +2 more
wiley   +1 more source

Implementation and Practice for Image-guided Stereotactic Body Radiotherapy

open access: yes
Krajem svibnja 2024. godine prijavio sam se za stipendiju putem ENEN-a (European Nuclear Education Network) kako bih sudjelovao u edukaciji koju organizira ESTRO (European Society for Radiotherapy and Oncology) pod nazivom „Implementation and Practice ...
Balentović, Ivan
core   +1 more source

Development of a phantom‐based end‐to‐end QA workflow for online adaptive radiotherapy incorporating high‐resolution 2D detector measurements

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 11, November 2026.
Abstract Background Online adaptive radiotherapy (oART) accounts for anatomical changes by adjusting treatment plans on a daily basis. However, comprehensive plan‐specific quality assurance (QA) is challenging, as pre‐treatment measurements cannot be performed with the patient on the treatment couch.
Julian Niedling   +4 more
wiley   +1 more source

Clinical outcomes of stereotactic body radiotherapy for de novo pulmonary tumors in patients with completely resected early stage non-small cell lung cancer

open access: yes, 2018
Qianqian Zhao, Gang Chen, Luxi Ye, Zhaochong Zeng, Shiming Shi, Jian He Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China Purpose: Following surgery for early stage non-small-cell lung cancer (NSCLC), de novo ...
Ye L   +5 more
core  

RTHistory: An automated tool for the extraction and presentation of radiotherapy course history for continuity of care applications

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 11, November 2026.
Abstract Background Transfer of radiation treatment records is a common task for radiotherapy clinics, as treatment history impacts future treatment planning, including prescription dose, fractionation, and normal tissue constraint selections. Currently, gathering radiation records relies on manual searches within treatment planning databases and ...
Justin B. Hink   +6 more
wiley   +1 more source

Advanced Materials for Biologics Delivery to Brain Tumors

open access: yesAdvanced Materials, Volume 38, Issue 61, 2 November 2026.
Material innovation is central to unlocking the therapeutic potential of biologics against many central nervous system diseases, including brain cancer. By engineering carriers with controlled transport, targeting, and release properties, advanced materials can overcome the blood–brain barrier and tumor microenvironment, improving the delivery of ...
Yuran Feng   +4 more
wiley   +1 more source

Metabolic Reprogramming in Glioblastoma Stem Cells Promotes Radiation Resistance Through a H3K18la/USP30/MBOAT2 Axis

open access: yesAdvanced Science, Volume 13, Issue 61, 3 November 2026.
LDHA‐driven lactate production in mesenchymal glioma stem cells promotes p300‐dependent H3K18 lactylation, activates USP30 transcription, and stabilizes MBOAT2 to remodel phosphatidylethanolamines toward ferroptosis‐resistant PE‐MUFA species. Disrupting this metabolic–epigenetic–lipid circuit enhances ferroptosis and sensitizes glioblastoma to ...
Zong Miao   +13 more
wiley   +1 more source

Stereotactic Body Radiotherapy for Extracranial Oligometastatic Renal Cell Carcinoma: State of the Art and Future Perspectives

open access: yesTechnology in Cancer Research & Treatment
Traditionally, radiotherapy in metastatic renal cell carcinoma (RCC) was applied for the palliation of symptoms and the control of critical sites such as bone lesions and brain metastases. However, technological advances in radiotherapy (RT) planning and
Sander Vandaele MD   +6 more
doaj   +1 more source

Chemotherapy‐Activated GSK3β‐DNMT1 Signaling Upregulates CD47 to Evade Macrophage Phagocytosis and Drive Temozolomide Resistance in Glioblastoma

open access: yesAdvanced Science, Volume 13, Issue 64, 16 November 2026.
Temozolomide treatment activates GSK3β, driving DNMT1 phosphorylation, destabilization, and CD47 promoter hypomethylation in glioblastoma. This epigenetic shift upregulates CD47, enabling TMZ‐treated GBM cells to evade macrophage phagocytosis, survive chemotherapy, and acquire resistance.
Jie Li   +11 more
wiley   +1 more source

Multicenter Retrospective Study of the Impact of Localized Therapy on Prognosis in Patients With Oligometastatic Solid Tumors

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Background Local therapy has recently been applied to treat oligometastatic cancer across various malignant cancers. However, definitive evidence for local treatment regimens remains lacking. We aimed to evaluate the clinical outcomes of combining local therapy with systemic treatment for patients with oligometastatic solid tumors including ...
Xueman Deng   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy